Orakl Oncology
Biology x AI-powered drug development platform to transform precision oncology.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Orakl Oncology. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 39 people
- Headquarters
- Paris, Île-de-France
- Type
- Privately Held
- Total funding
- $15.7M
Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.
Biotechnology
Medical
Oncology
Therapeutics
